Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | XDH | P47989 | 7/20 | 0.42 |
| ▸ | PNP | P00491 | 4/20 | 0.38 |
| ▸ | TK1 | P04183 | 2/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | EDNRA | P25101 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | HBB | P68871 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | HPRT1 | P00492 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22326671 | 0.84 | HPGD (0.43) | HPGDXDHPNPTK1TSHR | |
| SCHEMBL21137208 | 0.83 | XDH (0.55) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL22399377 | 0.81 | XDH (0.38) | XDHPNPTK1BLMUSP2 | |
| SCHEMBL24236963 | 0.79 | HPGD (0.46) | HPGDXDHPNPTK1BLM | |
| SCHEMBL23679502 | 0.76 | HPGD (0.46) | HPGDXDHPNPTK1BLM | |
| SCHEMBL3427614 | 0.76 | CDK1 (0.47) | HPGDXDHPNPTK1MEN1 | |
| SCHEMBL21943445 | 0.73 | HPGD (0.42) | HPGDXDHPNPBLMHBB | |
| SCHEMBL21127785 | 0.72 | HPRT1 (0.48) | PNPHPRT1MEN1KMT2AALDH1A1 | |
| SCHEMBL26199546 | 0.72 | PNP (0.47) | HPGDPNPTK1BLMUSP2 | |
| SCHEMBL22901682 | 0.72 | HPGD (0.43) | HPGDXDHPNPTK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11685761-B2 | Cyclic di-nucleotide compounds as sting agonists | MERCK SHARP & DOHME LLC (US) | 2023-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11685761-B2 | Cyclic di-nucleotide compounds as sting agonists | STING1, CGAS, IFNAR1 | HPGD 1650/4885XDH 16/4885PNP 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.